Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2011-03-29
2011-03-29
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C514S167000
Reexamination Certificate
active
07914823
ABSTRACT:
A method and composition for the treatment of diabetic neuropathy is disclosed. The composition comprises a cold compounded mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant formulated in a pharmaceutically acceptable carrier. It has been found that this combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In view of the consensus in the art that effective combinations of various active agents have not been demonstrated to be effective for the treatment of diabetic neuropathy, the present invention provides a surprising and unexpected effect. In addition, the topical compositions of the present invention, when used in effective amounts to treat diabetic neuropathy, do not exhibit the severe side effects of many prior art compositions proposed for treatment of this ailment.In a second aspect, a method for the topical administration of a composition in accordance with the present invention for the treatment of diabetic neuropathy is disclosed. In the method, an effective amount of the composition of the invention is topically administered to the areas of the body that have been adversely affected by the diabetic neuropathy on a regular basis over a period of time sufficient to provide the beneficial effects of relief from the symptoms and at least some recovery of the damaged nerve tissues.
REFERENCES:
patent: 4147795 (1979-04-01), Sarges
patent: 4210667 (1980-07-01), Sarges et al.
patent: 4232040 (1980-11-01), Waterbury
patent: 4250097 (1981-02-01), Pfister
patent: 4591600 (1986-05-01), Creuzet et al.
patent: 4617187 (1986-10-01), Okuyama et al.
patent: 4627973 (1986-12-01), Moran et al.
patent: 4822816 (1989-04-01), Markham
patent: 4997649 (1991-03-01), Papaconstantin et al.
patent: 5011840 (1991-04-01), Sarges
patent: 5043323 (1991-08-01), Bombardelli et al.
patent: 5070085 (1991-12-01), Markham
patent: 5122536 (1992-06-01), Perricone
patent: 5194248 (1993-03-01), Holick
patent: 5545398 (1996-08-01), Perricone
patent: 5550249 (1996-08-01), Della Valle et al.
patent: 5561110 (1996-10-01), Michaelis et al.
patent: 5571441 (1996-11-01), Andon et al.
patent: 5574063 (1996-11-01), Perricone
patent: 5595982 (1997-01-01), Harless
patent: 5607666 (1997-03-01), Masson et al.
patent: 5614224 (1997-03-01), Womack
patent: 5626868 (1997-05-01), Morancais et al.
patent: 5626883 (1997-05-01), Paul
patent: 5648083 (1997-07-01), Blieszner et al.
patent: 5660818 (1997-08-01), Dubief et al.
patent: 5665360 (1997-09-01), Mann
patent: 5665367 (1997-09-01), Burger et al.
patent: 5686082 (1997-11-01), N'Guyen
patent: 5686367 (1997-11-01), Hayashi
patent: 5709868 (1998-01-01), Perricone
patent: 5710177 (1998-01-01), Sauermann et al.
patent: 5725844 (1998-03-01), Gers-Barlag et al.
patent: 5770260 (1998-06-01), Fukuyama et al.
patent: 5776460 (1998-07-01), Kim et al.
patent: 5804168 (1998-09-01), Murad
patent: 5824666 (1998-10-01), Deckner et al.
patent: 5840736 (1998-11-01), Zelle et al.
patent: 5866578 (1999-02-01), Mylari et al.
patent: 5872140 (1999-02-01), Hesse et al.
patent: 5876737 (1999-03-01), Schonrock et al.
patent: 5883086 (1999-03-01), Craft
patent: 5922335 (1999-07-01), Ptchelintsev
patent: 5928670 (1999-07-01), Kador et al.
patent: 5948443 (1999-09-01), Riley et al.
patent: 5952391 (1999-09-01), Gers-Barlag et al.
patent: 5958379 (1999-09-01), Regenold et al.
patent: 5972359 (1999-10-01), Sine et al.
patent: 5972923 (1999-10-01), Simpkins et al.
patent: 5972999 (1999-10-01), Murad
patent: 5976568 (1999-11-01), Riley
patent: 5976579 (1999-11-01), McLean
patent: 5977184 (1999-11-01), Birdsall et al.
patent: 5981594 (1999-11-01), Okamoto et al.
patent: 5998394 (1999-12-01), Voorhees et al.
patent: 6048886 (2000-04-01), Neigut
patent: 6051602 (2000-04-01), Bissett
patent: 6054128 (2000-04-01), Wakat
patent: 6069168 (2000-05-01), Horrobin et al.
patent: 6103709 (2000-08-01), Norman et al.
patent: 6103756 (2000-08-01), Gorsek
patent: 6121243 (2000-09-01), Lanzendorfer et al.
patent: 6162801 (2000-12-01), Kita
patent: 6296861 (2001-10-01), Perricone
patent: 6299896 (2001-10-01), Cooper et al.
patent: 6391344 (2002-05-01), Kosaka et al.
patent: 6423747 (2002-07-01), Lanzendorfer et al.
patent: 6444221 (2002-09-01), Shapiro
patent: 6451837 (2002-09-01), Baskys
patent: 6455057 (2002-09-01), Barrett et al.
patent: 6555573 (2003-04-01), Rosenbloom
patent: 6562794 (2003-05-01), Lanzendorfer et al.
patent: 6576660 (2003-06-01), Liao et al.
patent: 6592896 (2003-07-01), Rosenbloom
patent: 6596313 (2003-07-01), Rosenbloom
patent: 6596761 (2003-07-01), Lanzendorfer et al.
patent: 7083813 (2006-08-01), Rosenbloom
patent: 7410659 (2008-08-01), Rosenbloom
patent: 2001/0031744 (2001-10-01), Kosbab
patent: 2280093 (1998-06-01), None
patent: 1283037 (2003-02-01), None
patent: 60-120812 (1985-06-01), None
patent: 60120812 (1985-06-01), None
patent: 01096106 (1989-04-01), None
patent: 3232851 (1991-10-01), None
patent: 07324037 (1995-12-01), None
patent: 200080044 (2000-03-01), None
patent: 96262607 (1996-08-01), None
patent: WO 97/18817 (1997-05-01), None
patent: 9831381 (1998-07-01), None
patent: 9841113 (1998-09-01), None
patent: 0011968 (2000-03-01), None
patent: 0035848 (2000-06-01), None
patent: 0059522 (2000-10-01), None
Fukuoka, M. et al., “Novel pharmacological activity of a vitamin (novel pharmacological action of vitamin D)”, Medscape Medline abstract, Nippon Yakurigaku Zasshi Oct. 1997, 110 Suppl. 1:39P-43P.
Riaz S. et al., “A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats”, Medscape Medline Abstract, Diabetologia Nov. 1999, 42(11): 1308-1313.
Okada, Y. et al., “Search for naturally occuring substances to prevent the complications of diabetes II . Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation.”, Medscape Medline Abstract, Chem. Pharm Bull (Tokyo) Aug. 1995, 43(8):1385-1387.
Hardman, J. G. Editor-in-Chief of Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Edition, pp. 1493-1498, 1996.
Holick, M.F., “Noncalcemic Actions of 1,25-Dihydroxyvitamin D3 and Clinical Applications,” Bone, vol. 3, No. 2, pp. 107S-111S (1995).
Riaz, S., et al, “A Vitamin D3 Derivative (CB1093) Induces Nerve Growth Factor and Prevents Neurotrophic Deficits in Streptozotocin-Diabetic Rats,” Diabetologia, vol. 42, No. 11, pp. 1308-1313 (Abstract)(1999).
Bravenboer, B., et al., “Potential Use of Glutathione for the Prevention and Treatment of Diabetic Neuropathy in the Streptozotocin-Induced Diabetic Rat,” Diabetologia, vol. 35, pp. 813-817 (1992).
Riaz et al. (Diabetologia, 42:1308-1313, 1999).
Nuraliev et al, The Efficacy Of Quercetin In Alloxan Diabetes, Eksperimental 'naia I klinicheskaia farmakologiia (Jan.-Feb. 1992) 55 (1) 42-4.
Riaz, S. et al., “A Vitamin D3 Derivative (CB1093) Induces Nerve Growth Factor and Prevents Neurotrophic Deficits in Streptozotocin-Diabetic Rats,” Diabetologia, 1999, pp. 1308-1313, vol. 42, No. 11. Chemical Abstract No. 131:332572.
Masami Fukuoka et al., “Novel Pharmacalogical Action of Vitamin D,” Folia Pharmacology Japan, 1997, pp. 39-43, vol. 110, Supplement No. 1.
Kengo Maeda et al., “Diabetic Neuropathy: Clinical and Experimental Progress in its Pathogenesis and Treatment,” Nippon Rinshou, 1999, pp. 88-93, vol. 57, No. 3.
Hotta, N. “Diagnosis and Treatment of Diabetic Neuropathies,” Nippon Naika Gakkai Zasshi, 1999, pp. 145-151, vol. 88, No. 11.
Igakunoayumi, 1999, pp. 597-601, vol. 188, No. 5.
Gendaiiryou, 1998, pp. 144-150, vol. 30, No. 10.
Iryou Journal, 1997, pp. 175-180, vol. 33, No. 10.
Baird, Stuart A. et al., “Anhydrosis in the Diabetic Foot: A Comparison of Two Urea Creams—Research,” The Diabetic Foot, 2003.
Fukuoka, Masami et al., “Tacalcito
Baek Bong-Sook
Knoble & Yoshida & Dunleavy LLC
Marschel Ardin
Prophase Labs, Inc.
LandOfFree
Method and composition for the topical treatment of diabetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for the topical treatment of diabetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for the topical treatment of diabetic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2667877